Dehydrojuncuenin ACAS# 1161681-26-0 |
Quality Control & MSDS
Package In Stock
Number of papers citing our products
| Cas No. | 1161681-26-0 | SDF | Download SDF |
| PubChem ID | N/A | Appearance | Powder |
| Formula | C18H16O | M.Wt | 248.3 |
| Type of Compound | Phenols | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
Dehydrojuncuenin A Dilution Calculator
Dehydrojuncuenin A Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 4.0274 mL | 20.1369 mL | 40.2739 mL | 80.5477 mL | 100.6847 mL |
| 5 mM | 0.8055 mL | 4.0274 mL | 8.0548 mL | 16.1095 mL | 20.1369 mL |
| 10 mM | 0.4027 mL | 2.0137 mL | 4.0274 mL | 8.0548 mL | 10.0685 mL |
| 50 mM | 0.0805 mL | 0.4027 mL | 0.8055 mL | 1.611 mL | 2.0137 mL |
| 100 mM | 0.0403 mL | 0.2014 mL | 0.4027 mL | 0.8055 mL | 1.0068 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Lehmbachol D
Catalog No.:BCN9244
CAS No.:913556-40-8
- Cinchonain Ia
Catalog No.:BCN9243
CAS No.:85081-24-9
- Otophylloside T
Catalog No.:BCN9242
CAS No.:1642306-14-6
- Periplanetin
Catalog No.:BCN9241
CAS No.:21056-52-0
- Sepiumol C
Catalog No.:BCN9240
CAS No.:2412138-09-9
- Alnusonol
Catalog No.:BCN9239
CAS No.:52330-12-8
- Carpinontriol A
Catalog No.:BCN9238
CAS No.:473451-72-8
- Qingyangshengenin 3-O-β-D-oleandropyranosyl-(1→4)-β-D-cymaropyranosyl-(1→4)-β-D-digitoxopyranoside
Catalog No.:BCN9237
CAS No.:1186628-88-5
- (R)-4-Methoxydalbergione
Catalog No.:BCN9236
CAS No.:4646-86-0
- 2-(2,4-Dihydroxybenzoyl)benzoic acid
Catalog No.:BCN9235
CAS No.:2513-33-9
- 4-Hydroxy-2,3-dimethoxyxanthone
Catalog No.:BCN9234
CAS No.:10527-38-5
- Rhamnazin
Catalog No.:BCN9233
CAS No.:552-54-5
- Periplocoside O
Catalog No.:BCN9246
CAS No.:116709-67-2
- Qingyangshengenin 3-O-β-D-cymaropyranosyl-(1→4)-β-D-digitoxopyranoside
Catalog No.:BCN9247
CAS No.:1186628-87-4
- Dictysine
Catalog No.:BCN9248
CAS No.:67256-05-7
- Murrayanine
Catalog No.:BCN9249
CAS No.:723-97-7
- Dauricumine
Catalog No.:BCN9250
CAS No.:345641-00-1
- 1,6-Dimethyl-5-vinyl-9,10-dihydrophenanthren-2-ol
Catalog No.:BCN9251
CAS No.:745056-83-1
- Jinflexin A
Catalog No.:BCN9252
CAS No.:2055155-75-2
- 2-Methoxy-1,6-dimethyl-5-vinyl-9,10-dihydrophenanthren-7-ol
Catalog No.:BCN9253
CAS No.:2266586-31-4
- 16,23-Oxidoalisol B
Catalog No.:BCN9254
CAS No.:169326-06-1
- Cinchonain Ib
Catalog No.:BCN9255
CAS No.:85022-69-1
- 5-O-Methyllatifolin
Catalog No.:BCN9256
CAS No.:18525-14-9
- Matairesinol monoglucoside
Catalog No.:BCN9257
CAS No.:34446-06-5
Anxiolytic effect of a novel 9,10-dihydrophenanthrene, juncuenin H, is associated with metabolic changes in cortical serotonin/dopamine levels in mice.[Pubmed:30825572]
Fitoterapia. 2019 Apr;134:165-171.
Two novel phenanthrenoids, juncuenin H (1) and dijuncuenin B (2), together with eight known phenanthrenoids, effusol (3), dehydroeffusol (4), juncusol (5), dehydrojuncusol (6), juncuenin B (7), dehydrojuncuenin B (8), juncuenin A (9), and Dehydrojuncuenin A (10), were isolated from the underground parts of Juncus setchuenensis. The structures of the compounds were determined by 1D and 2D NMR and mass spectroscopy. The anxiolytic activities of compounds 1, 6, 9, and 10 were evaluated. In order to explore the mechanisms underlying their anxiolytic activities, the levels of serotonin (5-HT), dopamine (DA), and their metabolites in the cerebral cortex and hippocampus of mice treated with compound 1 were determined by quantitative mass spectrometry. The mice treated with compound 1 had significantly lower levels of 5-HT, 3-methoxytyramine (3-MT), 5-hydroxyindole-3-acetic acid (5-HIAA), homovanillic acid (HVA), and 3, 4-dihydroxyphenylacetic acid (DOPAC) in the cerebral cortex than those of the vehicle control-treated mice. The levels of HVA and 5-HIAA in the hippocampus were also significantly lower in the mice treated with compound 1 than in the control group mice. These results suggest that the metabolic changes, reflected in the levels of DA and/or 5-HT, may contribute to the anxiolytic activity of the phenanthrenoids studied herein.
